Name: UMIN ID:
Unique ID issued by UMIN | UMIN000000720 |
---|---|
Receipt number | R000000859 |
Scientific Title | A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509) |
Date of disclosure of the study information | 2007/05/22 |
Last modified on | 2016/04/08 17:48:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2007/05/22 13:35:27 | ||
2 | Update | 2009/08/11 16:39:06 | Name of person sending information Name of person sending information Division name Division name TEL |
|
3 | Update | 2009/12/04 15:48:51 | Interventions/Control_2 |
|
4 | Update | 2009/12/04 15:49:40 | Institutions |
|
5 | Update | 2009/12/04 15:49:54 | Recruitment status |
|
6 | Update | 2010/12/09 17:47:22 | Last follow-up date |
|
7 | Update | 2011/08/04 10:26:23 | Last name of lead principal investigator Last name of lead principal investigator Division name Last name of contact person Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
8 | Update | 2011/08/04 10:27:05 | Recruitment status |
|
9 | Update | 2012/06/20 11:51:59 | Acronym |
|
10 | Update | 2013/07/12 11:38:17 | Institutions |
|
11 | Update | 2014/06/24 16:10:14 | Recruitment status Publication of results URL related to results and publications Results Results |
|
12 | Update | 2016/04/08 17:48:20 | Recruitment status |